Integrated treatment of chronic tonsillitis in children of preschool and early school age

Background. Currently, chronic tonsillitis (CT) retains one of the leading places in the overall structure of ENT diseases. According to Russian scientists, the incidence ranges from 10-12 to 22.1-40.1% in the pediatric population. Laser-assisted drug therapy is well suited for the treatment of CT, and the combined use of low-frequency ultrasound makes it possible to impregnate drugs into the submucous layer of the affected organ (in this case, the tonsils). Objective. Development of an integrated approach to the combined use of laser-assisted drug therapy and low-frequency ultrasound in the treatment of children of preschool and early school age with a diagnosis of CT, with frequent decompensations; demonstration of the benefits of this technique. Methods. 94 children aged 6 to 11 years with a reliably established diagnosis of chronic compensated tonsillitis were followed-up in outpatient settings. Patients were divided into 3 groups. The group 1 consisted of 29 children who received traditional drug treatment and placebo laser therapy using the Milta-F-8-01 apparatus in combination with placebo low-intensity ultraphonophoresis on the projection of the tonsils using the Tonsillor-MM apparatus; 33 children who received laser therapy using the Milta-F-8-01 apparatus and low-intensity ultraphonophoresis using the Tonsillor-MM apparatus represented group 2; and 32 patients in the group 3 received complex treatment using laser-assisted drug therapy and low-intensity phonophoresis with sterile viscous hydrogel material based on biopolymers on the projection of the tonsils using the Tonsillor-MM apparatus. Conclusion. A long-term effectiveness analysis has revealed the most positive results in the group of children who received combined physiotherapy: ultrasound and laser-assisted drug therapy simultaneously. A sterile viscous hydrogel material based on biopolymers with pharmaceuticals introduced into it was used as a medicine. The duration of follow-up period was 1 year. 31.38% of patients from the group 1 and 23.86% from the group 2 sought medical help for retreatment with exacerbation of CT, respectively. In the group 3, data on the recurrence of the process amounted to 16.66%.

chronic tonsillitis, laser therapy, laser-assisted drug therapy, ultrasound-assisted drug therapy